Finally, practical utility of the apelin to NT-proBNP ratio needs more investigation taking into consideration of a wide implementation of SGLT2 inhibitors in the therapy of both T2DM and HFpEF/HFrEF, because these agents seem to show a favorable effect of apelin and NT-proBNP [54]. Here, NPPB is linked to type 2 diabetes mellitus.